CASC
Cascadian Therapeutics, Inc.
CASC
CASC
Delisted
CASC was delisted on the 8th of March, 2018.
75 hedge funds and large institutions have $84.3M invested in Cascadian Therapeutics, Inc. in 2016 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 17 increasing their positions, 21 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
18% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 22
19% less repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 21
Holders
75
Holding in Top 10
1
Calls
$94K
Puts
$55K
Top Buyers
| 1 | +$23.6M | |
| 2 | +$10.1M | |
| 3 | +$1.58M | |
| 4 |
EAM
EverPoint Asset Management
Stamford,
Connecticut
|
+$1.42M |
| 5 |
Millennium Management
New York
|
+$601K |
Top Sellers
| 1 | -$2.06M | |
| 2 | -$1.46M | |
| 3 | -$1.41M | |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$846K |
| 5 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
-$751K |